Key Highlights
- ARK liquidated more than 213,000 Nvidia shares valued at approximately $37 million throughout the week
- The firm disposed of over 90,000 Meta Platforms shares representing nearly $50 million in value
- Bitcoin ETF holdings were reduced alongside sales of crypto-related equity Bullish
- New CoreWeave position established with 41,830 shares acquired for roughly $3.1 million
- Circle Internet Group emerged as ARK’s largest acquisition, with more than 161,000 shares totaling $16–17 million
Cathie Wood’s ARK Invest conducted extensive selling operations throughout the previous week. The investment firm systematically exited positions in mega-cap technology companies, artificial intelligence-related securities, cryptocurrency-linked equities, and consumer-facing internet platforms, while selectively establishing only a handful of fresh positions.
The most substantial divestment involved Nvidia. ARK liquidated a combined total exceeding 213,000 shares distributed across its three exchange-traded funds—ARKK, ARKW, and ARKF—representing more than $37 million in aggregate value. Advanced Micro Devices experienced the sale of upwards of 57,000 shares, while Taiwan Semiconductor saw reductions exceeding 18,000 shares. Broadcom likewise faced modest position trimming.
Teradyne represented another significant portfolio exit. ARK disposed of approximately 82,000 shares valued at roughly $24 million throughout the week, extending an established trend of position downsizing.
Regarding internet platforms and digital service companies, ARK liquidated more than 90,000 shares of Meta Platforms, representing a valuation approaching $50 million. Additional position reductions affected Alphabet, Netflix, Spotify, and Pinterest.
Cryptocurrency and Speculative Position Reductions
ARK diminished its stake in its proprietary ARK 21Shares Bitcoin ETF while maintaining its selling pattern in Bullish, an equity with cryptocurrency exposure. Block experienced approximately 107,000 shares sold, totaling more than $6 million.
High-growth innovation securities faced substantial reductions as well. Archer Aviation saw 899,000 shares eliminated from portfolios. Roku underwent a multi-session selling program totaling in excess of 234,000 shares. Recursion Pharmaceuticals lost 631,000 shares from ARK’s investment lineup.
Healthcare divestments encompassed Illumina, Veracyte, Ionis Pharmaceuticals, and Natera. Defense sector holdings Kratos and BWX Technologies also experienced reductions.
ARK’s Strategic Acquisitions
Purchasing operations remained constrained but strategically concentrated. Circle Internet Group distinguished itself as the predominant acquisition. ARK accumulated more than 161,000 shares distributed among ARKF, ARKK, and ARKW, representing between $16 million and $17 million in investment value.
Tempus AI constituted another significant purchase, with approximately 146,000 shares acquired across ARKK and ARKG, valued at around $7 million. 10x Genomics witnessed the addition of more than 121,000 shares, representing close to $2.5 million. Arcturus Therapeutics gained upwards of 53,000 shares.
Latest Single-Session Trading Activity
During Monday’s session on March 30, ARK acquired 41,830 shares of CoreWeave through its ARKK ETF, representing approximately $3.1 million in value.
That identical trading day saw ARK purchase 37,422 shares of Oklo alongside 20,674 shares of GeneDx Holdings. DoorDash received a modest addition of 2,527 shares.
Concerning disposals that session, ARK eliminated 29,130 shares of Teradyne for approximately $8.6 million, while selling 42,818 shares of Veracyte for roughly $1.3 million.
The exclusive names incorporated into ARK’s acquisition roster throughout the complete week comprised Circle Internet, Tempus AI, 10x Genomics, Arcturus Therapeutics, CoreWeave, Oklo, and GeneDx.
